ANNX Competitors & Alternatives
Compare Annexon Inc with similar stocks in the same industry
Biotechnology
ANNX
Main Stock$3.49
-2.38%
Tradestie Score
42
Market Cap
$332.96M
Analyst Upside
+387.8%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$7.44
-1.46%
|
$799.70M | - | 62 | Compare |
|
KURA
Kura Oncology, Inc.
|
$7.46
+5.22%
|
$798.53M | - | 69 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$9.25
-3.44%
|
$791.82M | - | 48 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$7.15
-2.85%
|
$757.72M | - | 44 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$10.72
-7.27%
|
$748.90M | - | 40 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$14.24
-3.33%
|
$718.62M | 6.4 | 50 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$19.62
-0.63%
|
$715.25M | - | 35 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
+0.19%
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$142.94
-1.15%
|
$699.30M | - | 41 | Compare |
More ANNX Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry